Impact of Remote Monitoring Technologies for Assisting Patients With Gestational Diabetes Mellitus: A Systematic Review
| dc.contributor.author | Bertini, Ayleen | |
| dc.contributor.author | Gárate, Bárbara | |
| dc.contributor.author | Pardo, Fabián | |
| dc.contributor.author | Pelicand, Julie | |
| dc.contributor.author | Sobrevia, Luis [UNESP] | |
| dc.contributor.author | Torres, Romina | |
| dc.contributor.author | Chabert, Steren | |
| dc.contributor.author | Salas, Rodrigo | |
| dc.contributor.institution | Universidad de Valparaíso | |
| dc.contributor.institution | Pontificia Universidad Católica de Chile | |
| dc.contributor.institution | Universidad de Sevilla | |
| dc.contributor.institution | University of Queensland | |
| dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
| dc.contributor.institution | University of Groningen | |
| dc.contributor.institution | UMCG | |
| dc.contributor.institution | School of Medicine and Health Sciences | |
| dc.contributor.institution | Universidad Andres Bello | |
| dc.contributor.institution | Millennium Institute for Intelligent Healthcare Engineering | |
| dc.date.accessioned | 2022-04-28T19:52:42Z | |
| dc.date.available | 2022-04-28T19:52:42Z | |
| dc.date.issued | 2022-03-03 | |
| dc.description.abstract | Introduction: In Chile, 1 in 8 pregnant women of middle socioeconomic level has gestational diabetes mellitus (GDM), and in general, 5–10% of women with GDM develop type 2 diabetes after giving birth. Recently, various technological tools have emerged to assist patients with GDM to meet glycemic goals and facilitate constant glucose monitoring, making these tasks more straightforward and comfortable. Objective: To evaluate the impact of remote monitoring technologies in assisting patients with GDM to achieve glycemic goals, and know the respective advantages and disadvantages when it comes to reducing risk during pregnancy, both for the mother and her child. Methods: A total of 188 articles were obtained with the keywords “gestational diabetes mellitus,” “GDM,” “gestational diabetes,” added to the evaluation levels associated with “glucose level,” “glycemia,” “glycemic index,” “blood sugar,” and the technological proposal to evaluate with “glucometerm” “mobile application,” “mobile applications,” “technological tools,” “telemedicine,” “technovigilance,” “wearable” published during the period 2016–2021, excluding postpartum studies, from three scientific databases: PUBMED, Scopus and Web of Science. These were managed in the Mendeley platform and classified using the PRISMA method. Results: A total of 28 articles were selected after elimination according to inclusion and exclusion criteria. The main measurement was glycemia and 4 medical devices were found (glucometer: conventional, with an infrared port, with Bluetooth, Smart type and continuous glucose monitor), which together with digital technology allow specific functions through 2 identified digital platforms (mobile applications and online systems). In four articles, the postprandial glucose was lower in the Tele-GDM groups than in the control group. Benefits such as improved glycemic control, increased satisfaction and acceptability, maternal confidence, decreased gestational weight gain, knowledge of GDM, and other relevant aspects were observed. There were also positive comments regarding the optimization of the medical team’s time. Conclusion: The present review offers the opportunity to know about the respective advantages and disadvantages of remote monitoring technologies when it comes to reducing risk during pregnancy. GDM centered technology may help to evaluate outcomes and tailor personalized solutions to contribute to women’s health. More studies are needed to know the impact on a healthcare system. | en |
| dc.description.affiliation | Metabolic Diseases Research Laboratory (MDRL) Interdisciplinary Center for Research in Territorial Health of the Aconcagua Valley (CIISTe Aconcagua) Center for Biomedical Research Universidad de Valparaíso | |
| dc.description.affiliation | Programa de Doctorado en Ciencias e Ingeniería para La Salud Faculty of Medicine Universidad de Valparaíso | |
| dc.description.affiliation | School of Biomedical Engineering Faculty of Engineering Universidad de Valparaíso | |
| dc.description.affiliation | School of Medicine Campus San Felipe Faculty of Medicine Universidad de Valparaíso | |
| dc.description.affiliation | Cellular and Molecular Physiology Laboratory (CMPL) Department of Obstetrics Division of Obstetrics and Gynaecology School of Medicine Faculty of Medicine Pontificia Universidad Católica de Chile | |
| dc.description.affiliation | Department of Physiology Faculty of Pharmacy Universidad de Sevilla | |
| dc.description.affiliation | University of Queensland Centre for Clinical Research Faculty of Medicine and Biomedical Sciences University of Queensland | |
| dc.description.affiliation | Medical School (Faculty of Medicine Sao Paulo State University (UNESP | |
| dc.description.affiliation | Department of Pathology and Medical Biology University of Groningen | |
| dc.description.affiliation | University Medical Center Groningen UMCG | |
| dc.description.affiliation | Tecnologico de Monterrey Eutra The Institute for Obesity Research School of Medicine and Health Sciences | |
| dc.description.affiliation | Faculty of Engineering Universidad Andres Bello | |
| dc.description.affiliation | Millennium Institute for Intelligent Healthcare Engineering | |
| dc.description.affiliation | Centro de Investigación y Desarrollo en INGeniería en Salud—CINGS Universidad de Valparaíso | |
| dc.description.affiliationUnesp | Medical School (Faculty of Medicine Sao Paulo State University (UNESP | |
| dc.description.sponsorship | Agencia Nacional de Investigación y Desarrollo | |
| dc.description.sponsorshipId | Agencia Nacional de Investigación y Desarrollo: ICN 2021-004 | |
| dc.identifier | http://dx.doi.org/10.3389/fbioe.2022.819697 | |
| dc.identifier.citation | Frontiers in Bioengineering and Biotechnology, v. 10. | |
| dc.identifier.doi | 10.3389/fbioe.2022.819697 | |
| dc.identifier.issn | 2296-4185 | |
| dc.identifier.scopus | 2-s2.0-85127186226 | |
| dc.identifier.uri | http://hdl.handle.net/11449/223721 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Frontiers in Bioengineering and Biotechnology | |
| dc.source | Scopus | |
| dc.subject | gestational diabetes (GDM) | |
| dc.subject | mobile applications | |
| dc.subject | remote monitoring | |
| dc.subject | technovigilance | |
| dc.subject | telemedicine | |
| dc.title | Impact of Remote Monitoring Technologies for Assisting Patients With Gestational Diabetes Mellitus: A Systematic Review | en |
| dc.type | Resenha | pt |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | a3cdb24b-db92-40d9-b3af-2eacecf9f2ba | |
| relation.isOrgUnitOfPublication.latestForDiscovery | a3cdb24b-db92-40d9-b3af-2eacecf9f2ba | |
| unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |

